FIELD: biotechnology; medicine.
SUBSTANCE: invention relates to biotechnology and medicine, in particular to an improved method of screening, diagnosing and/or monitoring advanced colorectal neoplasia (AN), advanced adenoma (AA) and/or colorectal cancer (CRC), where AN includes CRC and AA. Invention further relates to the use of said method in selecting individuals for conducting an exploratory study (for example, colonoscopy) or treating by anticancer therapy.
EFFECT: method provides higher specificity due to reduced false-positive results in faecal occult blood test (FOBT) using a signature based on bacterial markers.
13 cl, 3 dwg, 6 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIAGNOSING COLORECTAL CANCER FROM HUMAN FECES SAMPLE BY QUANTITATIVE PCR, PRIMERS AND KIT | 2015 |
|
RU2692555C2 |
| METHOD FOR IN VITRO DIAGNOSIS OR PREDICTION OF COLORECTAL CANCER OR ITS PRECANCEROUS STAGE | 2020 |
|
RU2831090C2 |
| DETERMINING MICRORNA IN PLASMA FOR DETECTING COLORECTAL CANCER IN ITS EARLY STAGES | 2012 |
|
RU2662975C1 |
| MIRNA DEFINITION PLASMA FOR DETECTION OF EARLY STAGES OF COLORECTAL CANCER | 2012 |
|
RU2611189C2 |
| SCREENING METHOD OF COLORECTAL CANCER DIAGNOSING | 2021 |
|
RU2798058C2 |
| PRIMER KIT, REAGENT AND COMMERCIAL KIT FOR METHYLATION OF SPECIFIC GENE REGIONS ASSOCIATED WITH HUMAN COLORECTAL CANCER AND USE OF THE COMMERCIAL KIT | 2019 |
|
RU2791172C1 |
| PROTEIN SIGNATURE FOR DIAGNOSING COLORECTAL CANCER OR ITS PRECANCEROUS STAGE | 2020 |
|
RU2830580C2 |
| METHOD FOR NON-INVASIVE DIAGNOSIS OF COLORECTAL CANCER | 2015 |
|
RU2586775C1 |
| METHOD AND DEVICE FOR in vitro ANALYSIS OF GENE mRNA INVOLVED IN DEVELOPMENT OF HEMATOLOGIC NEOPLASIAS | 2006 |
|
RU2426786C2 |
| METHOD OF DIAGNOSING NEOPLASM-II | 2008 |
|
RU2565540C2 |
